RAPAd®

The RAPAd® method of Adenovirus construction, developed by ViraQuest Inc. scientists, has been used by other scientists around the world.

Request Quote

Confidentiality

 

Learn More

Quality Control

Plaque forming units guarantee. Non-detectable RCA.

Learn More

Turnaround Time

Sub-cloning to finished particles in about four weeks.

Learn More

Dual Expressers

Multiple transgene expression in a single virus.

Learn More

Tag Archives: Vaccine

Vaccine-induced CD8+ T cells control AIDS virus replication

Authors: Mudd PA, Martins MA, Ericsen AJ, Tully DC, Power KA, Bean AT, Piaskowski SM, Duan L, Seese A, Gladden AD, Weisgrau KL, Furlott JR, Kim YI, Veloso de Santana MG, Rakasz E, Capuano S 3rd, Wilson NA, Bonaldo MC, Galler R, Allison DB, Piatak M Jr, Haase AT, Lifson JD, Allen TM, Watkins DI
Citation: Nature. 2012 Nov 1;491(7422):129-33

read more

Human dendritic cells adenovirally-engineered to express three defined tumor antigens promote broad adaptive and innate immunity

Authors: Blalock LT, Landsberg J, Messmer M, Shi J, Pardee AD, Haskell R, Vujanovic L, Kirkwood JM, Butterfield LH
Citation: Oncoimmunology. 2012 May 1;1(3):287-357

read more

The efficacy of HSV-2 vaccines based on gD and gB is enhanced by the addition of ICP27

Authors: Bright H, Perez DL, Christy C, Cockle P, Eyles JE, Hammond D, Khodai T, Lang S, West K, Loudon PT
Citation: Vaccine. 2012 Dec 14;30(52):7529-35

read more

Immunization with adenoviral-vectored tick salivary gland proteins (SALPs) in a murine model of Lyme borreliosis

Authors: Ullmann AJ, Dolan MC, Sackal CA, Fikrig E, Piesman J, Zeidner NS
Citation: Ticks Tick Borne Dis. 2013 Feb;4(1-2):160-3

read more

Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.

Authors: Soboleski MR, Gabbard JD, Price GE, Misplon JA, Lo CY, Perez DR, Ye J, Tompkins SM, Epstein SL.
Citation: PLoS One. 2011;6(7):e21937.

read more

DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4? T cells, but few subdominant epitope-specific CD8? T cells.

Authors: Vojnov L, Bean AT, Peterson EJ, Chiuchiolo MJ, Sacha JB, Denes FS, Sandor M, Fuller DH, Fuller JT, Parks CL, McDermott AB, Wilson NA, Watkins DI.
Citation: Vaccine. 2011 Oct 6;29(43):7483-90.

read more

Vaccine-induced anti-tuberculosis protective immunity in mice correlates with the magnitude and quality of multifunctional CD4 T cells.

Authors: Derrick SC, Yabe IM, Yang A, Morris SL.
Citation: Vaccine. 2011 Apr 5;29(16):2902-9.

read more

Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver.

Authors: Desai MM, Gong B, Chan T, Davey RA, Soong L, Kolokoltsov AA, Sun J.
Citation: Gastroenterology. 2011 Aug;141(2):674-85, 685.e1-6.

read more

Single-dose mucosal immunization with a candidate universal influenza vaccine provides rapid protection from virulent H5N1, H3N2 and H1N1 viruses.

Authors: Price GE, Soboleski MR, Lo CY, Misplon JA, Quirion MR, Houser KV, Pearce MB, Pappas C, Tumpey TM, Epstein SL.
Citation: PLoS One. 2010 Oct 4;5(10):e13162.

read more

Genetic control of immune responses to influenza A matrix 2 protein (M2).

Authors: Misplon JA, Lo CY, Gabbard JD, Tompkins SM, Epstein SL.
Citation: Vaccine. 2010 Aug 16;28(36):5817-27.

read more